Related Experiment Videos
Chemotherapy of germ cell tumors: current status and future directions
1Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
European Urology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
In vivo differentiation and genomic evolution in adult male germ cell tumors.
Genes, chromosomes & cancer·2007
Expression of ID genes in differentiated elements of human male germ cell tumors.
Diagnostic molecular pathology : the American journal of surgical pathology, part B·2002
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines.
Cell and tissue research·2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
When CO2 sensing fails: Protective effects of sex hormones and potential mechanisms.
Journal of neuroendocrinology·2026
Survival in unresectable hepatocellular carcinoma: Comparison of four treatments based on patients reconstructed from Kaplan-Meier curves of randomized trials.
World journal of gastrointestinal pharmacology and therapeutics·2026
Acupuncture Suppresses the ER Stress-JNK Pathway to Inhibit Chondrocyte Apoptosis and Attenuate Knee Osteoarthritis.
Cell stress & chaperones·2026
Schisantherin B mitigates cisplatin-induced ototoxicity by modulating the CNPY2-PERK/CHOP signaling axis.
Biochemical pharmacology·2026